ArticleCancer medicine2019

Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12.

Xiaowei Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.